154 related articles for article (PubMed ID: 26212053)
21. From Molecular Mechanism to the Etiology of Sjogren Syndrome.
Wei W; Ahmad SS; Chi S; Xie Y; Kamal MA; Li J
Curr Pharm Des; 2018; 24(35):4177-4185. PubMed ID: 30332943
[TBL] [Abstract][Full Text] [Related]
22. Insight into pathogenesis of Sjögren's syndrome: Dissection on autoimmune infiltrates and epithelial cells.
Goules AV; Kapsogeorgou EK; Tzioufas AG
Clin Immunol; 2017 Sep; 182():30-40. PubMed ID: 28330683
[TBL] [Abstract][Full Text] [Related]
23. Sjögren's syndrome. Controversies and progress.
Fox RI
Clin Lab Med; 1997 Sep; 17(3):431-44. PubMed ID: 9316767
[TBL] [Abstract][Full Text] [Related]
24. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.
Ushio A; Arakaki R; Eguchi H; Hotta F; Yamada A; Kudo Y; Ishimaru N
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587293
[TBL] [Abstract][Full Text] [Related]
25. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
[TBL] [Abstract][Full Text] [Related]
26. [A case of Sjögren's syndrome at the age of 91 with a lymphoepithelial lesion].
Masaki Y; Sugai S; Takeshita S; Fukutoku M; Takeuchi Y; Yoshioka R; Arai T; Tachibana J; Shimizu S; Takiguchi T
Ryumachi; 1993 Apr; 33(2):175-9. PubMed ID: 8316909
[TBL] [Abstract][Full Text] [Related]
27. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
Soyfoo MS; Chivasso C; Perret J; Delporte C
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700
[TBL] [Abstract][Full Text] [Related]
28. [Diagnosis of primary Sjogren's syndrome].
Gran JT; Myklebust G
Tidsskr Nor Laegeforen; 2001 Feb; 121(5):563-6. PubMed ID: 11301610
[TBL] [Abstract][Full Text] [Related]
29. Differential immunological aberrations in patients with primary and secondary Sjögren's syndrome.
Kroneld U; Halse AK; Jonsson R; Bremell T; Tarkowski A; Carlsten H
Scand J Immunol; 1997 Jun; 45(6):698-705. PubMed ID: 9201311
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
Waterman SA; Gordon TP; Rischmueller M
Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
[TBL] [Abstract][Full Text] [Related]
31. Association of Anticentromere Antibodies With More Severe Exocrine Glandular Dysfunction in Sjögren's Syndrome: Analysis of the Sjögren's International Collaborative Clinical Alliance Cohort.
Baer AN; Medrano L; McAdams-DeMarco M; Gniadek TJ
Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1554-9. PubMed ID: 26867144
[TBL] [Abstract][Full Text] [Related]
32. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
33. Novel Sjögren's autoantibodies found in fibromyalgia patients with sicca and/or xerostomia.
Applbaum E; Lichtbroun A
Autoimmun Rev; 2019 Feb; 18(2):199-202. PubMed ID: 30572137
[TBL] [Abstract][Full Text] [Related]
34. The geoepidemiology of Sjögren's syndrome.
Mavragani CP; Moutsopoulos HM
Autoimmun Rev; 2010 Mar; 9(5):A305-10. PubMed ID: 19903539
[TBL] [Abstract][Full Text] [Related]
35. Long-term followup of patients with Sjögren's syndrome.
Kruize AA; Hené RJ; van der Heide A; Bodeutsch C; de Wilde PC; van Bijsterveld OP; de Jong J; Feltkamp TE; Kater L; Bijlsma JW
Arthritis Rheum; 1996 Feb; 39(2):297-303. PubMed ID: 8849383
[TBL] [Abstract][Full Text] [Related]
36. Cytokine markers of B lymphocytes in minor salivary gland infiltrates in Sjögren's syndrome.
Navarro-Mendoza EP; Aguirre-Valencia D; Posso-Osorio I; Correa-Forero SV; Torres-Cutiva DF; Loaiza D; Tobón GJ
Autoimmun Rev; 2018 Jul; 17(7):709-714. PubMed ID: 29729452
[TBL] [Abstract][Full Text] [Related]
37. Increased CCL25 and T Helper Cells Expressing CCR9 in the Salivary Glands of Patients With Primary Sjögren's Syndrome: Potential New Axis in Lymphoid Neogenesis.
Blokland SLM; Hillen MR; Kruize AA; Meller S; Homey B; Smithson GM; Radstake TRDJ; van Roon JAG
Arthritis Rheumatol; 2017 Oct; 69(10):2038-2051. PubMed ID: 28622456
[TBL] [Abstract][Full Text] [Related]
38. Endocrine alterations in primary Sjogren's syndrome: an overview.
Mavragani CP; Fragoulis GE; Moutsopoulos HM
J Autoimmun; 2012 Dec; 39(4):354-8. PubMed ID: 22695186
[TBL] [Abstract][Full Text] [Related]
39. Hematologic manifestations of primary Sjögren's syndrome.
Manganelli P; Fietta P; Quaini F
Clin Exp Rheumatol; 2006; 24(4):438-48. PubMed ID: 16956437
[TBL] [Abstract][Full Text] [Related]
40. Increased prevalence of antibodies to thyroid peroxidase in dry eyes and mouth syndrome or sicca asthenia polyalgia syndrome.
Mavragani CP; Skopouli FN; Moutsopoulos HM
J Rheumatol; 2009 Aug; 36(8):1626-30. PubMed ID: 19605678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
